Value Investing

  • Cramer’s Top 4 Picks to Complement Your Tech Portfolio

    Amidst AI stock fervor, Jim Cramer urges investors to look beyond tech and consider overlooked healthcare names for diversified growth. He highlights CVS Health for its competitive advantages, Cardinal Health for its pivot to services, Johnson & Johnson for its financial strength and pipeline, and UnitedHealth Group for its strong performance and data analytics. This strategy aims to balance portfolios and mitigate risks from potential tech corrections.

    2026年4月23日
  • Profiting from the Tech Exodus: An Industrial Stock Play

    Jim Cramer’s Charitable Trust is trimming its DuPont (DD) stake, selling 100 shares to focus on value and industrial sectors. This move capitalizes on DuPont’s strong recent performance, with the stock up significantly year-to-date and since its Qnity Electronics separation. The trust is realizing approximately a 48% gain, reflecting a market rotation from tech to value stocks. The trust maintains a disciplined trading strategy with alert systems and waiting periods.

    2026年2月14日
  • Royce Global Trust (RGT) – September 30, 2025

    Royce Global Trust (RGT), a global equity closed-end fund, reported its performance as of September 30, 2025. The fund employs a value-oriented approach, leveraging the advisor’s 50+ years of small/micro-cap experience. NAV was $15.03 and MKT was $12.95. Average annual total returns ranged from 1.35%-20.78% (NAV & MKT) for various periods. The fund invests in small/mid-cap companies, with notable holdings in Tel Aviv Stock Exchange and Sprott. Top sectors include Financials (30.3%) and Industrials (26.2%).

    2025年11月7日
  • Buffett’s Virtual Double Enters the Market: Can This AI Replica Really Trade for You?

    Warren Buffett, 94, steps back from public investing as developer Virattt launches “AI Hedge Fund,” an open-source simulator channeling strategies from nine legendary investors, including Buffett’s value principles and Graham’s frameworks. Tests showed a 14% return from a simulated $1M AAPL short (April 30-May 5) but mixed accuracy across FAANG+Tesla stocks (80% for single strategies, 60% for hybrid models). While praised for educational transparency in exposing financial metrics, the platform warns against commercial use due to data costs, model inconsistencies, and risks of algorithmic overreliance. LLM-based committee hybrids face alignment challenges, echoing historical quant fund pitfalls.

    2025年5月18日